Indivior PLC (LON:INDV – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 840.40 ($10.57) and traded as low as GBX 659.50 ($8.29). Indivior shares last traded at GBX 699.50 ($8.80), with a volume of 893,588 shares.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group reissued a “buy” rating and set a GBX 1,800 ($22.64) price target on shares of Indivior in a report on Tuesday, December 17th.
Get Our Latest Stock Analysis on INDV
Indivior Stock Performance
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Further Reading
- Five stocks we like better than Indivior
- Airline Stocks – Top Airline Stocks to Buy Now
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Basic Materials Stocks Investing
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Short Selling: How to Short a Stock
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.